April 2018, Moscow
Dr. Alexei Danilin took part in the strategic session of the Ministry of Economic Development and Trade of the Russian Federation "Business Opportunities in the Southeast Asia Countries". The prospects of the Russian high-tech business in the Southeast Asian countries were discussed. The general opinion is that the countries of Southeast Asia are an ideal place to enter the world market and a springboard for Russian high-tech business development.

December 2017, Zelenograd
Innotra LLC, Axbio Inc (USA), Elta LLC (Russia), and the Management of Technounity Zelenograd Enterprises Cluster ( have held negotiations concerning possible cooperation in the development of promising sequencing methods.

November 2017, Moscow
Experiments confirmed the high mechanical characteristics of protective diamond-like nanocoatings for surgical stents. The bending tensile strength of the coatings and the elasticity of the stents with applied coatings were studied for stents manufactured by Gore Co. (USA), as test specimens.

November 2017, Malaysia, Kuala-Lumpur
With the assistance of Innotra LLC, Kember Associates Ltd., (UK), and Micran (Russia), held negotiations in Kuala Lumpur, Malaysia, and signed a memorandum of understanding with ITRAMAS Co., (Malaysia). Potential areas of cooperation were outlined. (Photo)

September 2017, Vietnam
Dr. Alexei Danilin took part in the Russian-Vietnamese Intergovernmental Commission for Trade-Economical and Scientific-Technological Cooperation. (Photo)

June 2017, Moscow
Innotra LLC started recruiting a team of Russian specialists to participate in the development of Axbio Inc.’s (USA) new portable sequencers NGS (Next-Generation Sequencing). Site-directed mutagenesis began.

April 2017, Moscow
Dr. Alexei Danilin took part in the Russia-Indonesia Business Council ( held in the Embassy of Indonesia to the Russian Federation.

March 2017, Moscow
Negotiations between the Management of Innotra LLC and Axbio Inc (USA), led to an agreement on assistance to Axbio Inc in the incorporation and development of biotechnology businesses in the Russian Federation.